ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606985 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606985; 2) Community: the network communities that were significantly associated with the response to NSC 606985; 3) Molecule: the relationships between components within communities and NSC 606985; 4) MDR: the compounds that were significantly associated with the NSC 606985.

NSC Compound Enrichment Correlation
NSC 681644 Camptothecin Derivative 3.40252996142932e-005 0.83499447
NSC 697685 Null 3.40252996142932e-005 0.57443386
NSC 737518 Indenoisoquinoline derivative 3.40252996142932e-005 0.71784623
NSC 30706 2,5-Di(ethyleneimino)-1,4-benzoquinone 3.40252996142934e-005 0.5470434
NSC 57199 3-[o-[Bis(.beta.-chloroethyl)amino]phenyl]-DL-alanine 3.40252996142934e-005 0.65749476
NSC 729813 6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt 3.6295237294955e-006 0.79867665
NSC 727354 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline 6.95083784546613e-005 0.37367566
NSC 735037 Camptothecin Derivative 6.95083784546613e-005 0.76544711
NSC 684569 Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- 8.79213185492947e-005 0.019572239
Total:88  Current:88    [First] [Prev] [Next] [Last]